Differences in diffusion tensor imaging parameters of brain white matter tracts between patients with myotonic dystrophy type 1 and type 2 — a retrospective single-centre study

Edyta Maj, Tomasz Wolak, Joanna de Meulder, Katarzyna Janiszewska, Mikołaj Wojtaszek, Anna Kostera-Pruszczyk, Marek Gołębiowski, Anna Łusakowska

Vol 57, No 5 (2023)

Research Paper

Effect of series of periodic limb movements in sleep on blood pressure, heart rate and high frequency heart rate variability

Marta A. Malkiewicz, Malgorzata Grzywinska, Krzysztof S. Malinowski, Eemil Partinen, Markku Partinen, Wieslaw J. Cubala, Pawel J. Winklewski, Mariusz Sieminski

Vol 58, No 2 (2024)

Research Paper

Association between within-visit blood pressure variability, stroke, coronary heart disease, and cardiovascular mortality

Bhrugun Anisetti, Hossam Youssef, Ahamed M. Elkhair, Michelle P. Lin

Vol 57, No 5 (2023)

Research Paper

Latest bibliometrics of Polish Journal of Neurology and Neurosurgery

Zbigniew K. Wszolek, Łukasz Stolarczyk, Jarosław Sławek

Vol 57, No 4 (2023)

Editorial Note

Updates on pharmacological treatment for Alzheimer’s disease

Philip W. Tipton

Vol 58, No 2 (2024)

Invited Review Article

Serum amino acid profiling in differentiating clinical outcomes of multiple sclerosis

Łukasz Rzepiński, Piotr Kośliński, Mariusz Kowalewski, Marcin Koba, Zdzisław Maciejek

Vol 57, No 5 (2023)

Research Paper

Impact of treatment on blood-brain barrier impairment in Wilson’s disease

Monika Misztal, Anna Członkowska, Agnieszka Cudna, Anna Palejko, Tomasz Litwin, Agnieszka Piechal, Iwona Kurkowska-Jastrzębska

Vol 57, No 4 (2023)

Research Paper

Visual disturbances in patients with Parkinson’s Disease treated with oral medications or deep brain stimulation

Jakub Rusinek, Karolina Porębska, Katarzyna Sawczyńska, Magdalena Witkowska, Małgorzata Dec-Ćwiek

Vol 57, No 4 (2023)

Short Communication

Numb chin syndrome — a seemingly innocent symptom that can indicate a serious disease

Dariusz Dziubek

Vol 58, No 1 (2024)

Letter to the Editors

Cladribine tablets for highly active relapsing-remitting multiple sclerosis in Poland: a real-world, multi-centre, retrospective, cohort study during the COVID-19 pandemic

Adam Stępień, Aleksandra Pogoda-Wesołowska, Elżbieta Tokarz-Kupczyk, Agnieszka Słowik, Przemysław Puz, Monika Adamczyk-Sowa, Iwona Kurkowska-Jastrzębska, Alina Kułakowska, Monika Chorąży, Karolina Piasecka-Stryczyńska, Anna Jamróz-Wiśniewska, Helena Bartosik-Psujek, Konrad Rejdak

Vol 57, No 4 (2023)

Research Paper

Reoperations for degenerative spinal disease in Poland reported to the National Health Fund over 12 months with estimation of reoperation rate and of risk factors associated with reoperations

Michał Sobstyl

Vol 57, No 4 (2023)

Invited Editorial

Experience of treatment of chronic migraine with botulinum toxin type A among aesthetic medicine professionals in Poland

Magdalena Boczarska-Jedynak

Vol 57, No 4 (2023)

Research Paper

Clinical significance and prognostic value of serum autoantibody tests in multiple sclerosis

Samet Öncel, Şule Şule Dalkılıç, Saadet Sayan, Elif Darol, Ayşe Zafer, Derya Kara, Abdulkadir Tunç

Vol 58, No 1 (2024)

Research Paper

Response to ‘Before blaming levodopa/carbidopa intestinal gel for demyelinating polyneuropathy, all differential aetiologies must be ruled out’

Radosław Piekarski, Anna Roszmann, Jarosław Dulski, Jarosław Sławek

Vol 57, No 4 (2023)

Response to Letter to the Editors

Before blaming levodopa/carbidopa intestinal gel for demyelinating polyneuropathy, all differential aetiologies must be ruled out

Josef Finsterer

Vol 57, No 4 (2023)

Letter to the Editors